14.54

1.26% 0.2057

Mediwound Ltd (MDWD)

Overview News Price History Option Chain Discussions Forecast Stock Split

Mediwound Ltd stock is traded at $14.54, with a volume of 173.90K. It is up +1.26% in the last 24 hours and down -12.38% over the past month. MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Previous Close:

$14.33

Open:

$14.36

24h Volume:

173.90K

Relative Volume:

2.04

Market Cap:

$187.19M

Revenue:

$16.96M

Net Income/Loss:

$-23.88M

P/E Ratio:

-6.9317

EPS:

-2.097

Net Cash Flow:

$-20.66M

1W Performance:

-13.84%

1M Performance:

-12.38%

6M Performance:

-19.03%

1Y Performance:

-31.17%

1-Day Range:

$14.33

$15.44

1-Week Range:

$14.14

$17.02

52-Week Range:

$14.14

$22.50

Mediwound Ltd Stock (MDWD) Company Profile

Name

Mediwound Ltd

Sector

Healthcare (1114)

Industry

Biotechnology (624)

Phone

Address

Employee

121

Twitter

Next Earnings Date

2026-05-27

Latest SEC Filings

MDWD's Discussions on Twitter

Compare MDWD vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDWD Mediwound Ltd	14.56	184.17M	16.96M	-23.88M	-20.66M	-2.097
VRTX Vertex Pharmaceuticals Inc	444.63	110.97B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	623.12	65.81B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	838.87	51.03B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	302.70	39.47B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	152.09	32.53B	742.00K	-1.37B	-1.07B	-7.0731

Mediwound Ltd Stock (MDWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-02-25	Resumed	Oppenheimer	Outperform
May-02-25	Initiated	Alliance Global Partners	Buy
Feb-28-25	Initiated	Craig Hallum	Buy
Jul-16-24	Reiterated	Maxim Group	Buy
Dec-22-22	Initiated	Maxim Group	Buy
Jul-18-22	Resumed	Oppenheimer	Outperform
Sep-23-20	Initiated	BTIG Research	Buy
Nov-28-16	Initiated	Aegis Capital	Buy
Aug-17-16	Initiated	Wells Fargo	Outperform
Apr-16-14	Initiated	Oppenheimer	Outperform

View All

Mediwound Ltd Stock (MDWD) Latest News

09:23 AM

MDWD Reiterates by HC Wainwright & Co. -- Price Target Maintained at $36 - GuruFocus

09:23 AM

09:10 AM

Oppenheimer Adjusts MediWound Price Target to $32 From $33, Maintains Outperform Rating - marketscreener.com

09:10 AM

08:08 AM

MediWound Ltd. (NASDAQ:MDWD) Q1 2026 Earnings Call Transcript - Insider Monkey

08:08 AM

Mediwound Ltd (MDWD)

Mediwound Ltd Stock (MDWD) Company Profile

Compare MDWD vs VRTX, REGN, ARGX, ALNY, RVMD

Mediwound Ltd Stock (MDWD) Upgrades & Downgrades

Mediwound Ltd Stock (MDWD) Latest News

MDWD Reiterates by HC Wainwright & Co. -- Price Target Maintained at $36 - GuruFocus

Oppenheimer Adjusts MediWound Price Target to $32 From $33, Maintains Outperform Rating - marketscreener.com

MediWound Ltd. (NASDAQ:MDWD) Q1 2026 Earnings Call Transcript - Insider Monkey

MediWound: Q1 Earnings Snapshot - AOL.com

MediWound Q1 2026 Earnings Call Transcript - MarketBeat

MediWound (MDWD) Q1 Loss Of US$0.23 Per Share Reinforces Bearish Profitability Narratives - simplywall.st

Q3 2025 Mediwound Ltd Earnings Call Transcript - GuruFocus

MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue Challenges - GuruFocus

Oppenheimer lowers MediWound stock price target to $32 on revenue miss By Investing.com - Investing.com Australia

Oppenheimer lowers MediWound stock price target to $32 on revenue miss - Investing.com Australia

Q1 2026 Mediwound Ltd Earnings Call Transcript - GuruFocus

MediWound Q1 2026 earnings preview - MSN

MediWound Q1 Earnings Call Highlights - sharewise.com

MediWound (MDWD) Reports Q1 Revenue Below Expectations - GuruFocus

MediWound Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga

Mediwound Ltd reports results for the quarter ended March 31Earnings Summary - TradingView

MediWound Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

MEDIWOUND ($MDWD) Releases Q1 2026 Earnings - Quiver Quantitative

MediWound Q1 2026 Results Highlight EscharEx Trial Progress and BARDA Boost for NexoBrid - TipRanks

MDWD: Q1 revenue fell but margin improved; EscharEx and NexoBrid progress support 2026 outlook - TradingView

MediWound (NASDAQ: MDWD) Q1 2026 revenue drops as 2026 guidance held - Stock Titan

MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update - Caledonian Record

US $197M BARDA deal to stock MediWound burn drug NexoBrid - Stock Titan

MediWound (MDWD) Prepares for Q1 2026 Earnings Report - GuruFocus

MDWD Q4 2025 Earnings: Narrower Loss Beats Estimates as Operational Focus ContinuesProduct Revenue Analysis - The Legal Advocate

(MDWD) Risk Channels and Responsive Allocation - Stock Traders Daily

Mediwound Ltd expected to post a loss of 65 cents a shareEarnings Preview - TradingView

MediWound Ltd. (MDWD) Holds Near Support as Minor Decline Tests Key FloorShared Momentum Picks - Newser

MDWD PE Ratio & Valuation, Is MDWD Overvalued - Intellectia AI

MediWound Ltd. (MDWD) Presents at European Wound Management Association (EWMA) 2026Slideshow - Seeking Alpha

[SCHEDULE 13G] MediWound Ltd. Passive Investment Disclosure (>5%) - Stock Titan

TradingKey - TradingKey

(MDWD) Movement as an Input in Quant Signal Sets - Stock Traders Daily

The real story behind MediWound (MDWD) valuation (Trend Weakens) 2026-05-08Gap Up Stocks - newser.com

MediWound to Report First Quarter 2026 Financial Results - Moomoo

MDWD Technical Analysis & ETF Price Forecast - Intellectia AI

May 27 at 8:30 a.m.: MediWound to discuss Q1 results, update - Stock Titan

MediWound Shareholders Back Board, Auditor and CEO Bonus at 2026 Annual Meeting - TipRanks

MediWound | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16] - Moomoo

Strong MediWound (MDWD) support for board and proposals at 2026 meeting - Stock Titan

MediWound | 20-F: FY2025 Annual Report - Moomoo

Liquidity Mapping Around (MDWD) Price Events - Stock Traders Daily

MediWound Ltd. (NASDAQ:MDWD) Given Consensus Rating of "Hold" by Analysts - MarketBeat

MediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market - TipRanks

Why (MDWD) Price Action Is Critical for Tactical Trading - Stock Traders Daily

MediWound (NASDAQ:MDWD) Share Price Crosses Above Fifty Day Moving AverageTime to Sell? - MarketBeat

Is MediWound (MDWD) stock forming a trend channel (Technical Weakness) 2026-04-20Income Investing - Cổng thông tin điện tử tỉnh Lào Cai

Shmuel Hess Net Worth (2026) - GuruFocus

Vickie Rae Driver Net Worth (2026) - GuruFocus

Kalfon Hana Luxenburg Net Worth (2026) - GuruFocus

Mediwound Ltd Stock (MDWD) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to MDWD